DAIC

+ Watchlist + Portfolio

CID HoldCo, Inc.

Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.79
52-Week Range: $0.37 – $78.75
Market Cap: $6.05M
P/E (TTM): —
EPS (TTM): -7.37
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: —
PEG Ratio: —
Return on Equity: —
Return on Assets: -91.01%
Gross Margin: 42.83%
Operating Margin: -24437.24%
Profit Margin: -276.85%
Current Ratio: 0.27
Debt/Equity: —
Total Debt: $2.35M
Free Cash Flow: $-7.23M
Revenue Growth: -90.20%
Earnings Growth: —
Enterprise Value: $7.94M

DAIC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$591.75K	$439.64K	$172.66K	$5.80M
Cost of Revenue	$148.56K	$86.89K	$43.63K	$3.13M
Gross Profit	$443.19K	$352.75K	$129.03K	$2.67M
Research & Development	$712.59K	$837.45K	$850.26K	$1.45M
Selling, General & Admin	$571.76K	$1.19M	$4.29M	$10.44M
Operating Expenses	$1.28M	$2.03M	$5.14M	$11.92M
Operating Income	-$841.16K	-$1.68M	-$5.01M	-$9.25M
EBITDA	-$959.42K	-$1.94M	-$21.54M	-$36.28M
Pretax Income	-$968.23K	-$1.94M	-$21.54M	-$36.72M
Income Tax	—	—	$581.00	$0.00
Net Income	-$968.23K	-$1.94M	-$21.54M	-$36.72M
Diluted EPS	-0.88	-1.75	-19.48	-44.50
Diluted Shares	1.11M	1.11M	1.11M	823198

DAIC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$826.58K	$605.76K	$721.03K	$865.62K
Receivables	$112.79K	$4.78K	$50.26K	$3.62M
Inventory	—	—	$65.25K	$1.43M
Current Assets	$939.89K	$766.38K	$1.00M	$6.40M
Total Assets	$1.19M	$1.69M	$3.10M	$10.70M
Current Liabilities	$50.43K	$44.11K	$2.22M	$8.13M
Total Debt	—	—	$301.64K	$2.26M
Total Liabilities	$2.27M	$4.65M	$27.39M	$10.46M
Retained Earnings	-$1.26M	-$3.20M	-$24.73M	-$61.45M
Shareholders' Equity	-$1.08M	-$2.95M	-$24.29M	$239.47K
Working Capital	$889.46K	$722.28K	-$1.22M	-$1.73M
Net Debt	—	—	—	$675.03K

DAIC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$877.36K	-$1.67M	-$3.29M	-$13.25M
Capital Expenditure	-$254.86K	-$672.32K	-$834.22K	-$1.83M
Free Cash Flow	-$1.13M	-$2.34M	-$4.12M	-$15.08M
Depreciation & Amortisation	—	—	$0.00	$36.46K
Stock-Based Compensation	$35.48K	$61.82K	$197.01K	$37.83K
Investing Cash Flow	-$254.86K	-$672.32K	-$834.22K	-$1.83M
Financing Cash Flow	$1.77M	$2.12M	$4.24M	$15.22M
Share Repurchases	-$26.77K	$0.00	$0.00	-$5.00M
Net Change in Cash	$632.97K	-$220.82K	$115.27K	$144.59K

DAIC Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$352.50K	$126.83K	$778.48K	$4.55M	$12.21K
Cost of Revenue	$17.08K	$67.19K	$488.29K	$2.56M	$2.67K
Gross Profit	$335.42K	$59.64K	$290.20K	$1.99M	$9.55K
Research & Development	$393.86K	$181.64K	$397.13K	$473.56K	$611.30K
Selling, General & Admin	$1.30M	$1.59M	$3.85M	$3.69M	$3.33M
Operating Expenses	$1.69M	$1.78M	$4.26M	$4.18M	$4.11M
Operating Income	-$1.36M	-$1.72M	-$3.97M	-$2.19M	-$4.10M
EBITDA	-$1.12M	-$28.65M	-$4.20M	-$2.26M	-$3.93M
Pretax Income	-$1.28M	-$28.86M	-$4.22M	-$2.36M	-$4.47M
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income	-$1.28M	-$28.86M	-$4.22M	-$2.36M	-$4.47M
Diluted EPS	-1.16	-50.00	-3.75	—	-3.75
Diluted Shares	1.11M	576578	1.11M	—	1.18M

DAIC Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$721.03K	$6.49M	$1.42M	$865.62K	$853.73K
Receivables	$50.26K	$15.94K	$915.03K	$3.62M	$101.97K
Inventory	$65.25K	$362.43K	$468.10K	$1.43M	$2.32M
Current Assets	$1.00M	$7.44M	$3.55M	$6.40M	$3.68M
Total Assets	$3.10M	$10.75M	$7.45M	$10.70M	$7.77M
Current Liabilities	$2.22M	$6.99M	$8.95M	$8.13M	$9.51M
Total Debt	$301.64K	$781.81K	$750.10K	$2.26M	$2.16M
Total Liabilities	$27.39M	$9.01M	$9.56M	$10.46M	$11.87M
Retained Earnings	-$24.73M	-$54.88M	-$59.09M	-$61.45M	-$65.92M
Shareholders' Equity	-$24.29M	$1.74M	-$2.12M	$239.47K	-$4.09M
Working Capital	-$1.22M	$454.04K	-$5.40M	-$1.73M	-$5.83M
Net Debt	—	—	—	$675.03K	$623.56K

DAIC Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$1.72M	-$2.04M	-$4.44M	-$5.05M	$93.81K
Capital Expenditure	-$278.41K	-$465.38K	-$638.72K	-$447.22K	—
Free Cash Flow	-$2.00M	-$2.51M	-$5.07M	-$5.50M	$93.81K
Depreciation & Amortisation	$0.00	$36.74K	-$19.90K	$19.62K	$167.04K
Stock-Based Compensation	$10.01K	$9.74K	$9.12K	$8.96K	$1.75K
Investing Cash Flow	-$278.41K	-$465.38K	-$638.72K	-$447.22K	$0.00
Financing Cash Flow	$1.62M	$8.65M	$0.00	$4.95M	-$105.70K
Share Repurchases	—	—	$0.00	$0.00	—
Net Change in Cash	-$376.13K	$6.15M	-$5.07M	-$553.21K	-$11.90K

Market Snapshot

About

CID HoldCo, Inc., formerly CIIG Capital Partners II, Inc., is a company that completed its business combination with Sera Prognostics in 2021. The combined entity focuses on developing and commercializing innovative biomarker tests to improve pregnancy outcomes. The company's flagship product is the PreTRM test, designed to predict the risk of premature birth in pregnant women. CID HoldCo operates in the women's health diagnostics market, utilizing proteomics technology to address critical maternal and fetal health challenges.